CCN2 and neoplasm: All mice treated with CTGF/E7 DNA vaccine and everolimus (G7), 80% of mice treated with CTGF/E7 DNA vaccine and rapamycin (G6) and 20% of mice treated with CTGF/E7 DNA vaccine and temsirolimus (G8) were alive 100 days after TC-1 tumor challenge.